Skip to content
buyModerate cluster of 4

Alison A Cornell bought $100k of ZIVO

director at Zivo Bioscience, Inc.. 11,709 shares at an average of $8.54, traded Jan 26, 2026, filed Jan 28, 2026.

Conviction score
48
Value
$100k
11,709 shares
Holdings after
279,481
+4% from before
From 52-week low
+40%
low $6.96, close $9.75
From 52-week high
-55%
high $21.49, as of Jan 26, 2026

Score components

  • Role
    Director
    +15
  • Trade size
    $100k at market
    +10
  • Relative to holdings
    Holdings up 4.4%
    0
  • Price context
    55% below the 52-week high
    +8
  • Cluster
    4 insiders buying within 14 days
    +15
  • Repeat buying
    First buy in 90 days
    0
  • Track record
    Too few past buys to judge (0 with prices)
    0

What happened after comparable buys

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

This signal so far: 1m +4.4%, 3m -61.9%, 6m -55.6%.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

ZIVOOct 12, 2026 · close 5.30
Since filing Jan 28, 2026: -41.1%SPY +12.8% · excess -53.9%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001654954-26-000652, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Jan 26, 2026POpen-market purchase
Common Stock
+11,709$8.54$100k279,481Jan 28, 2026

Related signals

Other insiders at Zivo Bioscience, Inc. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
43Moderate
ZIVObuy
Zivo Bioscience, Inc.
Mark E Strome
owner
$200k
100,000 shares
+21%
23Weak
ZIVObuy
Zivo Bioscience, Inc.
Laith L Yaldoo
director, owner
$15k
1,543 shares
+0%
35Weak
ZIVObuy 2
Zivo Bioscience, Inc.
Mark E Strome
owner
$195k
20,000 shares
+4%
31Weak
ZIVObuy 2
Zivo Bioscience, Inc.
Laith L Yaldoo
director, owner
$25k
2,434 shares
+0%
68Notable
ZIVObuy 4
Zivo Bioscience, Inc.
John Bernard Payne
President and CEO
$100k
11,709 shares
+148%
33Weak
ZIVObuy 4
Zivo Bioscience, Inc.
Christopher D. Maggiore
director, owner
$15k
1,766 shares
+0%
38Weak
ZIVObuy 4
Zivo Bioscience, Inc.
Laith L Yaldoo
director, owner
$15k
1,766 shares
+0%
23Weak
ZIVObuy
Zivo Bioscience, Inc.
Laith L Yaldoo
director, owner
$25k
2,777 shares
+0%
43Moderate
ZIVObuy 3
Zivo Bioscience, Inc.
Mark E Strome
owner
$250k
20,259 shares
+5%
38Weak
ZIVObuy 3
Zivo Bioscience, Inc.
Laith L Yaldoo
director, owner
$20k
1,659 shares
+0%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Alison A Cornell bought $100k of ZIVO | InsiderTell